Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the “frenzy” of weight loss drugs.

While Novo Nordisk and rival obesity therapy manufacturer Eli Lilly are starting to overcome the production constraints that ...

Ahead of a Senate health committee hearing next week with Novo Nordisk CEO Lars Jørgensen, Sen. Bernie Sanders claims he has ...

(Reuters) - Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders ...

Scattered investor qualms about Nuvalent Inc.’s largely upbeat data during the European Society for Medical Oncology (ESMO) ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health ...

The map of the human brain is not a static image of the cellular architecture of the central nervous system (CNS). Throughout ...